Handelsinvest Investeringsforvaltning’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,498
Closed -$760K 117
2018
Q3
$760K Buy
8,498
+2,805
+49% +$248K 0.16% 88
2018
Q2
$452K Hold
5,693
0.1% 93
2018
Q1
$508K Sell
5,693
-1,500
-21% -$144K 0.11% 89
2017
Q4
$751K Hold
7,193
0.17% 83
2017
Q3
$1.05M Hold
7,193
0.25% 69
2017
Q2
$934K Sell
7,193
-18,707
-72% -$2.29M 0.24% 68
2017
Q1
$3.22M Hold
25,900
0.92% 39
2016
Q4
$3M Buy
25,900
+10,000
+63% +$1.11M 1.05% 37
2016
Q3
$1.66M Hold
15,900
0.6% 69
2016
Q2
$1.57M Hold
15,900
0.6% 74
2016
Q1
$1.59M Hold
15,900
0.54% 73
2015
Q4
$1.9M Buy
+15,900
New +$1.84M 0.67% 61

Other funds holding CELG

Handelsinvest Investeringsforvaltning's CELG Position: Q4 2018 in Review

Handelsinvest Investeringsforvaltning sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 8,498 shares — an estimated $760K sold.

Handelsinvest Investeringsforvaltning first reported a position in CELG in Q4 2015 and held it in 12 quarters. The position peaked at $3.22M in Q1 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Handelsinvest Investeringsforvaltning reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 8,498 Celgene Corp shares in Q4 2018, an estimated $760K.
  • Handelsinvest Investeringsforvaltning first reported a position in Celgene Corp in Q4 2015 and held it in 12 quarters.
  • Handelsinvest Investeringsforvaltning's Celgene Corp position peaked at $3.22M in Q1 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2018, filed 22 Jan 2019.